Clinical Scenarios for Long-term Monitoring of Epileptic Seizures With a Wearable Biopotential Technology

NACompletedINTERVENTIONAL
Enrollment

496

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Epilepsy
Interventions
DEVICE

Sensor Dot

Multimodal (EEG, ECG, EMG and motion) seizure monitoring with Sensor Dot to complement EMU-based video-EEG monitoring (EMU Phase), and optional home-based seizure diary logging (Home Phase).

Trial Locations (7)

3000

University Hospitals Leuven, department of Neurology, Leuven

Unknown

Department of Epileptology and Neurology, Aachen

Epilepsy Center, University Medical Center, Freiburg University, Freiburg im Breisgau

Division of Neurology, Coimbra University Hospital, Coimbra

Department of Clinical Neuroscience, Karolinska Institute, Stockholm

Division of Neuroscience, King's College London, London

Nuffield Department of Clinical Neurosciences, Oxford University Hospital, Oxford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Freiburg University

UNKNOWN

collaborator

King's College London

OTHER

collaborator

Oxford University Hospitals NHS Trust

OTHER

collaborator

University of Coimbra

OTHER

collaborator

Karolinska Institutet

OTHER

collaborator

RWTH Aachen University

OTHER

collaborator

UCB Pharma

INDUSTRY

collaborator

Byteflies

INDUSTRY

collaborator

Helpilepsy

UNKNOWN

lead

Universitaire Ziekenhuizen KU Leuven

OTHER